rs397514398
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001370658.1(BTD):c.992delC(p.Thr331LysfsTer12) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,848 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001370658.1 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTD | NM_001370658.1 | c.992delC | p.Thr331LysfsTer12 | frameshift_variant | Exon 4 of 4 | ENST00000643237.3 | NP_001357587.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461848Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727234
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Biotinidase deficiency Pathogenic:3
This sequence change creates a premature translational stop signal (p.Thr351Lysfs*12) in the BTD gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 193 amino acid(s) of the BTD protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with profound biotinidase deficiency (PMID: 12359137, 15776412, 20083419). ClinVar contains an entry for this variant (Variation ID: 25057). This variant disrupts a region of the BTD protein in which other variant(s) (p.Leu498Phefs*13) have been determined to be pathogenic (PMID: 17382128, 19728141, 29359854). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
not provided Pathogenic:2
The c.1052delC variant in the BTD gene has been reported previously in association with biotinidase deficiency (Wolf et al. 2002; Iqbal et al. 2010; Gannavarapu et al. 2015). The c.1052delC variant has been reported to be associated with profound biotinidase deficiency in a patient who also harbored a second frameshift variant as well as in a patient homozygous for c.1052delC (Wolf et al. 2002; Iqbal et al. 2010). However, a second patient homozygous for c.1052delC was reported with partial biotinidase deficiency (Iqbal et al. 2010). The c.1052delC deletion causes a frameshift starting with codon Threonine 351, changes this amino acid to a Lysine residue and creates a premature Stop codon at position 12 of the new reading frame, denoted p.Thr351LysfsX12. This pathogenic variant is predicted to cause loss of normal protein function through protein truncation. The c.1052delC variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, we interpret c.1052delC to be a pathogenic variant. -
The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one symptomatic patient, and not found in general population data. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at